Steven W Kaldor

Title: Steven W Kaldor: Innovator in MAPK/ERK Kinase Inhibitors

Introduction

Steven W Kaldor is a notable inventor based in Del Mar, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of MAPK/ERK kinase inhibitors. His work has implications for various therapeutic applications.

Latest Patents

Kaldor holds a patent for MAPK/ERK kinase inhibitors. The patent describes compounds of a specific formula for use with MEK (I), where the variables are defined within the documentation. Additionally, the patent includes pharmaceutical compositions, kits, and articles of manufacture that comprise these compounds. It also outlines methods and intermediates useful for synthesizing the compounds, as well as methods for utilizing them in various applications.

Career Highlights

Kaldor is associated with Takeda Pharmaceutical Company Limited, where he has been instrumental in advancing research and development in his area of expertise. His innovative approach has contributed to the company's portfolio of pharmaceutical solutions.

Collaborations

Kaldor has collaborated with notable colleagues, including Qing Dong and Nicholas Scorah. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Steven W Kaldor's work in the field of MAPK/ERK kinase inhibitors exemplifies the impact of innovative research in pharmaceuticals. His contributions continue to influence the development of new therapeutic options.